FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 1870534 · Received October 15, 2010

Report

Report Number
2124215-2010-16931
Event Type
Injury
Date Received
October 15, 2010
Date of Event
August 24, 2010
Report Date
August 24, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PERICARDIAL EFFUSION WAS SUCCESSFULLY DRAINED AND THE PATIENT MOVED TO ICU FOR MONITORING. NO ALLEGATIONS AGAINST BSC PRODUCTS AS A CAUSE OR CONTRIBUTOR TO THE OBSERVED CLINICAL OBSERVATION. THE LEAD REMAINS IMPLANTED AND IN SERVICE.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT AT THE CONCLUSION OF SYSTEM IMPLANT, THE PATIENT EXHIBITED SUSTAINED HYPOTENSION REQUIRING INOTROPIC SUPPORT. A TRANSTHORACIC ECHOCARDIOGRAPHY WAS PERFORMED, NOTING EVIDENCE OF A PERICARDIAL EFFUSION; NO HEMODYNAMIC COLLAPSE OBSERVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4097

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention